Dren Bio

Developer of therapeutic antibodies for the treatment of cancer, autoimmune, and other serious diseases

placeSan Carlos, California, United States calendar_todayFounded 2019 groups50 employees language drenbio.com

Innovation

9 patent families (2 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace steady. Cited 309 times.

YearFilings
20202
20212
20224
20236
20245
20259

Social engagement

Social engagement: 4.4K social following, 2 posts in the last 12 months — below the industry typical range.

Investor mix

15 investors on record; lead investors include SR One, Taiho Ventures, 8VC, HBM Healthcare Investments.

Investor typeCountShare
Venture capital747%
Private equity427%
Other / undisclosed427%

Hiring activity

No recent openings observed

No roles tracked in the last 12 months

30 Oct 2025 · Director of Clinical QA · San Carlos

27 Sep 2025 · Associate Director/ Director, Regulatory Affairs · Foster City

30 Aug 2025 · Associate Scientist/ Scientist I, Translational Sciences · Foster City

Based on job postings tracked across public sources.

Recent activity

29 Oct 2025
Recognition
8 Aug 2025
Expansion
San Francisco Peninsula
Coming soon